For these reasons, we explored the role of S1PR2/3 in fatty liver injury and asked whether S1PR2/3 could be effective therapeutic targets for inhibiting inflammation and alleviating liver fibrosis in vivo. This evidence concerns the gene S1PR2 and fatty liver disease.